Clinical Trial Update: Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting results from a Phase 2/3 study of temozolomide with or without veliparib in newly diagnosed glioblastoma, with the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Temodar (Temozolomide)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioblastoma, Gliosarcoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-04-04